search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
131 new news items in the last 24 hours
  1. Home
  2. International

AstraZeneca recorded a net profit of 10.2 billion dollars in 2025, with a 45% increase due to sales of cancer drugs.

Gabriel Dumitrache
whatsapp
facebook
linkedin
x
copy-link copy-link
10 February 2026, 13:23
main event image
International
Foto: Shutterstock
google-preference

Always see our news on Google

AstraZeneca, the British pharmaceutical giant, announced on Tuesday a 45% increase in net profit in 2025, reaching 10.2 billion dollars, compared to 7 billion dollars in the previous year. Revenues grew by 9%, reaching 58.7 billion dollars, due to strong sales of cancer drugs. CEO Pascal Soriot highlighted the solid commercial performance and excellent deliveries from the company's pipeline, expressing confidence that AstraZeneca will achieve an annual revenue of 80 billion dollars by the end of the decade.

The company is expanding its presence in the US and China markets, investing 15 billion dollars in China by 2030 and aiming for the US to represent half of global revenues by 2030. Additionally, AstraZeneca has begun to list its shares on the New York Stock Exchange to attract more investors, in the context of threats of tariffs imposed by President Trump on the pharmaceutical industry.

Sources

sursa imagine
France24
AstraZeneca profit jumps as cancer drug sales grow
sursa imagine
independent.co.uk
AstraZeneca profits jump by 40% amid strong demand for cancer drugs
sursa imagine
The Guardian EU
AstraZeneca CEO hails NHS drug price deal but keeps pause on £200m UK investment

Latest News

22:21

Eugen Tomac calls for reforming public administration and says that the option of eight regions can be analyzed

22:02

Traian Băsescu says Marian Neacșu will be the “executive prime minister” of the Luca Niculescu Government

21:35

The Environmental Guard discovered mercury and hazardous substances in an abandoned laboratory in central Bucharest

21:10

Traian Băsescu says that the Trump-Putin-Xi meeting will target the renegotiation of treaties concerning nuclear weapons: “The stake is not the division of the world”

20:58

Italy’s government is allocating seven billion euros and preparing a “cyber army” of 5,000 operators

See more news

NEWS ON THE SAME TOPICS

event image
Economy
Saudi Aramco giant's profit rose to 31.2 billion dollars in Q3 amid the war in Iran
event image
Economy
Nvidia reported a net profit more than double compared to last year. Revenues exceeded analysts' forecasts.
event image
Economy
OnlyFans reports a record profit of 714 million dollars in 2025
event image
Economy
Stellantis shares rise after quarterly results beat expectations and the company reaffirmed its financial targets
event image
Economy
Chevron and ExxonMobil hit record highs after doubling their profits amid the global fuel crisis
event image
Economy
Ropharma reports a net profit of 5.7 million lei, an increase of 627% compared to last year.
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
AstraZeneca profit cancer United Kingdom medically

Editor’s Recommendations

main event image
INSCOP Surveys
13 hours ago

November 2026: Informat.ro – INSCOP Research BAROMETER, 15th Edition – Chapter IX: Freedom vs. Security

main event image
Exclusive
12 hours ago

Exclusive Monitor of Ministers by NewsVibe: November 12–18, 2026 / Rogobete, Nazare and Neacșu top online visibility amid the Lyrica controversy and state-owned company reform

main event image
Exclusive
6 hours ago

DOC Anthropic debuts Thursday on Nasdaq: the biggest test of the market’s enthusiasm for artificial intelligence

main event image
Current Affairs
10 hours ago

SUMMARY Earthquake alerts: why Japan warns the population before the arrival of strong seismic waves, while Romania does not use RO-Alert

main event image
Exclusive
6 hours ago

EXCLUSIVE Ranking of countries in relevant Romanian online sources: Ukraine leads the foreign agenda. Security and the economy define the week

main event image
Opinions
9 hours ago

Raed Arafat, a Mr. Bean at DSU

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol